Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Izikki, S. Adnot, P. Zadigue, A. M. Barlier Mur, B. Maitre, B. Raffestin, S. Eddahibi (Creteil, France). Effect of roflumilast on hypoxia- and monocrotaline-induced pulmonary hypertension in rats. Eur Respir J 2007; 30: Suppl. 51, 1836

Member's Comments

No comment yet.

Related content which might interest you: Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil Source: Eur Respir J 2010; 36: 800-807 Year: 2010 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats Source: Eur Respir J 2005; 26: Suppl. 49, 291s Year: 2005 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 2-Methoxyestrone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Effects of iloprost and the phosphodiesterase inhibitor tolafentrine on pulmonary vascular remodelling in chronic experimental pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 20s Year: 2003 VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Effects of HIV protease inhibitors on monocrotaline-induced pulmonary hypertension in rats Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Effects of Sildenafil on hypoxic pulmonary vasoconstriction in dogs Source: Eur Respir J 2001; 18: Suppl. 33, 490s Year: 2001 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Effects of fasudil in patients with high-altitude pulmonary hypertension Source: Eur Respir J 2012; 39: 496-498 Year: 2012 Reversibility of the monocrotaline pulmonary hypertension rat model Source: Eur Respir J 2013; 42: 553-556 Year: 2013 The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Inhaled iloprost reverses chronic experimental pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 353s Year: 2005 Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002 Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2009; 34: 731 Year: 2009 Inflammatory changes in a murine model of monocrotaline-induced pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 365s Year: 2005